< Back to companies
Algorithmiq

Algorithmiq

Quantum drug discovery at light speed

Helsinki, Finland

Algorithmiq is a quantum computing company that develops advanced algorithms to solve complex problems in drug discovery and molecular structure prediction, aiming to make the process faster and more cost-effective.

Algorithmiq hero image

Close
Algorithmiq hero image
Share
Shareable draft
Algorithmiq logo
Get Involved in Algorithmiq

1 engagement

How We Help

Problem Statement

Drug discovery and design are computationally complex, making them slow, inefficient, and costly with classical computers. Algorithmiq addresses this by using advanced quantum algorithms to accelerate and improve the accuracy of molecular simulations.

Core Technology

Quantum Computing

Key Differentiators

Development of noise-resilient quantum algorithms; Seamless integration of classical and quantum computing; Quantum Network Medicine approach combining AI with quantum computing; Informationally Complete framework for error mitigation

Clinical Focus

Drug Discovery; Molecular Simulation; Drug Metabolism; Photodynamic Cancer Therapy; Epilepsy Research; Cell Biology

Company Info

Business Model
Hybrid
Founded
2020
Total Funding
Only accessible to MedStartr community members. Join now
Website
algorithmiq.fi

Categories

Drug Discovery/Development

Disease Areas

Technologies

Quantum ComputingQuantum AlgorithmsDrug DiscoveryMolecular SimulationError MitigationAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Finalist in Wellcome Leap Quantum for Bio Challenge; $4.25M award for photon-activated cancer drug research with Cleveland Clinic and IBM; validated error mitigation at IBM Quantum Summit 2023

Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Algorithmiq?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Algorithmiq

1 engagement

💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free